Twenty-first century mast cell stabilizers

British Journal of Pharmacology

Volumn 170, Issue 1, 2013, Pages 23-37

  Finn, D F ^a   Walsh, J J ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

allergy; anti IgE; disodium cromoglycate; inhibitors; mast cell; mediator release; natural products; sensitization

Indexed keywords

ALKALOID DERIVATIVE; AMINO ACID DERIVATIVE; APIGENIN; ARTEKEISKEANOL A; CINNAMIC ACID; COUMARIN; COUMARIN DERIVATIVE; DIOSMETIN; ELLAGIC ACID; EPIGALLOCATECHIN GALLATE; FISETIN; FLAVONE; FLAVONOID; FUROCOUMARIN; GINKGETIN; IMMUNOLOGIC AGENT; KAEMPFEROL; LUTEOLIN; MAST CELL STABILIZER; PHENOL DERIVATIVE; QUERCETIN; SCAPORONE; SCOPOLETIN; SELINIDIN; SILIBININ; SILYMARIN; TERPENOID DERIVATIVE; THUNBERGINOL A; THUNBERGINOL B; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALLERGIC REACTION; CELL FUNCTION; CONCENTRATION RESPONSE; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; MAST CELL DEGRANULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ALLERGY; ANTI-IGE; DISODIUM CROMOGLYCATE; INHIBITORS; MAST CELL; MEDIATOR RELEASE; NATURAL PRODUCTS; SENSITIZATION;

ALLERGENS; ANIMALS; ANTI-ALLERGIC AGENTS; BIOLOGICAL PRODUCTS; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; DRUG DESIGN; HUMANS; HYPERSENSITIVITY; MAST CELLS;

EID: 84881647283     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12138     Document Type: Review

References (104)

1. Barlow JW, Walsh JJ, (2008). Synthesis and evaluation of 4-amino-3,4-dihydro-2H-naphthalen-1-one derivatives as mast cell stabilising and anti-inflammatory compounds. Eur J Med Chem 43: 2891-2900.
2. Barlow JW, Walsh JJ, (2010). Synthesis and evaluation of dimeric 1,2,3,4-tetrahydro-naphthalenylamine and indan-1-ylamine derivatives with mast cell-stabilising and anti-allergic activity. Eur J Med Chem 45: 25-37.
3. Barlow JW, McHugh AP, Woods O, Walsh JJ, (2011a). Synthesis of novel mast cell-stabilising and anti-allergic 1,2,3,4-tetrahydro-1-naphthalenols and related compounds. Eur J Med Chem 46: 1545-1554.
4. Barlow JW, Zhang T, Woods O, Byrne AJ, Walsh JJ, (2011b). Novel Mast Cell-Stabilising Amine Derivatives of 3,4 Dihydronaphthalen-1(2H)-one and 6,7,8,9-Tetrahydro-5H-benzo[7]annulen-5-one. Med Chem. 7: 213-223.
5. Boswell-Smith V, Spina D, Page CP, (2006). Phosphodiesterase inhibitors. Br J Pharmacol 147 (Suppl. 1): S252-S257.
6. Buku A, Condie BA, Price JA, Mezei M, (2005). [Ala12]MCD peptide: a lead peptide to inhibitors of immunoglobulin E binding to mast cell receptors. J Pept Res 66: 132-137.
7. Buku A, Keselman I, Lupyan D, Mezei M, Price JA, (2008). Effective mast cell degranulating peptide inhibitors of the IgE/Fc epsilonRI receptor interaction. Chem Biol Drug Des 72: 133-139.
8. Byrne AJ, Barlow JW, Walsh JJ, (2011). Synthesis and pharmacological evaluation of the individual stereoisomers of 3-[methyl(1,2,3,4-tetrahydro-2- naphthalenyl)amino]-1-indanone, a potent mast cell stabilising agent. Bioorg Med Chem Lett 21: 1191-1194.
9. Cho SH, Woo CH, Yoon SB, Kim JH, (2004). Protein kinase Cdelta functions downstream of Ca2+ mobilization in FcepsilonRI signaling to degranulation in mast cells. J Allergy Clin Immunol 114: 1085-1092.
10. Choi YH, Yan GH, (2009a). Anti-allergic effects of scoparone on mast cell-mediated allergy model. Phytomedicine 16: 1089-1094.
11. Choi YH, Yan GH, (2009b). Ellagic Acid attenuates immunoglobulin E-mediated allergic response in mast cells. Biol Pharm Bull 32: 1118-1121.
12. Choi YH, Yan GH, (2009c). Silibinin attenuates mast cell-mediated anaphylaxis-like reactions. Biol Pharm Bull 32: 868-875.
13. D'cruz OJ, Uckun FM, (2007). Targeting mast cells in endometriosis with janus kinase 3 inhibitor, JANEX-1. Am J Reprod Immunol 58: 75-97.
14. Dugan LL, Turetsky DM, Du C, Lobner D, Wheeler M, Almli CR, et al. (1997). Carboxyfullerenes as neuroprotective agents. Proc Natl Acad Sci U S A 94: 9434-9439.
15. El-Agamy DS, (2012). Anti-allergic effects of nilotinib on mast cell-mediated anaphylaxis like reactions. Eur J Pharmacol 680: 115-121.
16. Erdei A, Toth GK, Andrasfalvy M, Matko J, Bene L, Bajtay Z, et al. (1999). Inhibition of IgE-mediated triggering of mast cells by complement-derived peptides interacting with the Fc epsilon RI. Immunol Lett 68: 79-82.
17. Erin N, Ersoy Y, Ercan F, Akici A, Oktay S, (2004). NK-1 antagonist CP99994 inhibits stress-induced mast cell degranulation in rats. Clin Exp Dermatol 29: 644-648.
18. Farrell R, Kelleher F, Sheridan H, (1996). Synthesis of fern sesquiterpenes pterosin Z via a novel palladium-catalyzed route. J Nat Prod 59: 446-447.
19. Fensome-Green A, Stannard N, Li M, Bolsover S, Cockcroft S, (2007). Bromoenol lactone, an inhibitor of Group V1A calcium-independent phospholipase A2 inhibits antigen-stimulated mast cell exocytosis without blocking Ca2+ influx. Cell Calcium 41: 145-153.
20. Frankish N, Farrell R, Sheridan H, (2004). Investigation into the mast cell stabilizing activity of nature-identical and synthetic indanones. J Pharm Pharmacol 56: 1423-1427.
21. Fujimoto M, Oka T, Murata T, Hori M, Ozaki H, (2009). Fluvastatin inhibits mast cell degranulation without changing the cytoplasmic Ca2+ level. Eur J Pharmacol 602: 432-438.
22. Galli SJ, Tsai M, (2008). Mast cells: versatile regulators of inflammation, tissue remodeling, host defense and homeostasis. J Dermatol Sci 49: 7-19.
23. Galli SJ, Grimbaldeston M, Tsai M, (2008). Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 8: 478-486.
24. Gibbs BF, Schmutzler W, Vollrath IB, Brosthardt P, Braam U, Wolff HH, et al. (1999). Ambroxol inhibits the release of histamine, leukotrienes and cytokines from human leukocytes and mast cells. Inflamm Res 48: 86-93.
25. Han SJ, Bae EA, Trinh HT, Yang JH, Youn UJ, Bae KH, et al. (2007). Magnolol and honokiol: inhibitors against mouse passive cutaneous anaphylaxis reaction and scratching behaviors. Biol Pharm Bull 30: 2201-2203.
26. Hazen SL, Zupan LA, Weiss RH, Getman DP, Gross RW, (1991). Suicide inhibition of canine myocardial cytosolic calcium-independent phospholipase A2. Mechanism-based discrimination between calcium-dependent and -independent phospholipases A2. J Biol Chem 266: 7227-7232.
27. He S, Xie H, (2004). Modulation of tryptase and histamine release from human lung mast cells by protease inhibitors. Asian Pac J Allergy Immunol 22: 205-212.
28. Hikino H, Miyase T, Takemoto T, (1976). Biosynthesis of pteroside B in Pteridium aquilinum var. Latiusculum, proof of the sesquiterpenoid origin of the pterosides. Phytochemistry 15: 121-123.
29. Hirano T, Higa S, Arimitsu J, Naka T, Ogata A, Shima Y, et al. (2006). Luteolin, a flavonoid, inhibits AP-1 activation by basophils. Biochem Biophys Res Commun 340: 1-7.
30. Hong J, Sasaki H, Hirasawa N, Ishihara K, Kwak JH, Zee O, et al. (2009). Suppression of the antigen-stimulated RBL-2H3 mast cell activation by Artekeiskeanol A. Planta Med 75: 1494-1498.
31. Hua JM, Moon TC, Hong TG, Park KM, Son JK, Chang HW, (2008). 5-Methoxy-8-(2-hydroxy-3-buthoxy-3-methylbutyloxy)-psoralen isolated from Angelica dahurica inhibits cyclooxygenase-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. Arch Pharm Res 31: 617-621.
32. Huang F, Yamaki K, Tong X, Fu L, Zhang R, Cai Y, et al. (2008). Inhibition of the antigen-induced activation of RBL-2H3 cells by sinomenine. Int Immunopharmacol 8: 502-507.
33. Inoue T, Suzuki Y, Ra C, (2010). Epigallocatechin-3-gallate inhibits mast cell degranulation, leukotriene C4 secretion, and calcium influx via mitochondrial calcium dysfunction. Free Radic Biol Med 49: 632-640.
34. Itoh T, Ohguchi K, Iinuma M, Nozawa Y, Akao Y, (2008). Inhibitory effect of xanthones isolated from the pericarp of Garcinia mangostana L. on rat basophilic leukemia RBL-2H3 cell degranulation. Bioorg Med Chem 16: 4500-4508.
35. Itoh T, Oyama M, Takimoto N, Kato C, Nozawa Y, Akao Y, et al. (2009). Inhibitory effects of sesquiterpene lactones isolated from Eupatorium chinense L. on IgE-mediated degranulation in rat basophilic leukemia RBL-2H3 cells and passive cutaneous anaphylaxis reaction in mice. Bioorg Med Chem 17: 3189-3197.
36. Jensen BM, Beaven MA, Iwaki S, Metcalfe DD, Gilfillan AM, (2008). Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: coordinated suppression of mast cell activation. J Pharmacol Exp Ther 324: 128-138.
37. Kang OH, Jang HJ, Chae HS, Oh YC, Choi JG, Lee YS, et al. (2009). Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-kappaB and MAPK. Pharmacol Res 59: 330-337.
38. Kawakami T, Inagaki N, Takei M, Fukamachi H, Coggeshall KM, Ishizaka K, et al. (1992). Tyrosine phosphorylation is required for mast cell activation by Fc epsilon RI cross-linking. J Immunol 148: 3513-3519.
39. Kempuraj D, Madhappan B, Christodoulou S, Boucher W, Cao J, Papadopoulou N, et al. (2005). Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol 145: 934-944.
40. Kempuraj D, Castellani ML, Petrarca C, Frydas S, Conti P, Theoharides TC, et al. (2006). Inhibitory effect of quercetin on tryptase and interleukin-6 release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line. Clin Exp Med 6: 150-156.
41. Kiefer S, Mertz AC, Koryakina A, Hamburger M, Kuenzi P, (2010). (E,Z)-3-(3′,5′-Dimethoxy-4′-hydroxy-benzylidene)-2-indolinone blocks mast cell degranulation. Eur J Pharm Sci 40: 143-147.
42. Kim JW, Lee JH, Hwang BY, Mun SH, Ko NY, Kim Do K, et al. (2009). Morin inhibits Fyn kinase in mast cells and IgE-mediated type I hypersensitivity response in vivo. Biochem Pharmacol 77: 1506-1512.
43. Kim K, Kim Y, Kim HY, Ro JY, Jeoung D, (2008). Inhibitory mechanism of anti-allergic peptides in RBL2H3 cells. Eur J Pharmacol 581: 191-203.
44. Kim NH, Jeong HJ, Kim HM, (2011). Theanine is a candidate amino acid for pharmacological stabilization of mast cells. Amino Acids 42: 1609-1618.
45. Kim SH, Lee S, Kim IK, Kwon TK, Moon JY, Park WH, et al. (2007). Suppression of mast cell-mediated allergic reaction by Amomum xanthiodes. Food Chem Toxicol 45: 2138-2144.
46. Kim Do K, Lee JH, Kim JW, Kim HS, Kim AR, Kim BK, et al. (2011). A novel imidazo[1,5-b]isoquinolinone derivative, U63A05, inhibits syk activation in mast cells to suppress IgE-mediated anaphylaxis in mice. J Pharmacol Sci 115: 500-508.
47. Kimata M, Inagaki N, Nagai H, (2000a). Effects of luteolin and other flavonoids on IgE-mediated allergic reactions. Planta Med 66: 25-29.
48. Kimata M, Shichijo M, Miura T, Serizawa I, Inagaki N, Nagai H, (2000b). Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin Exp Allergy 30: 501-508.
49. Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD, (1999). Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood 94: 2333-2342.
50. Kishiro S, Nunomura S, Nagai H, Akihisa T, Ra C, (2008). Selinidin suppresses IgE-mediated mast cell activation by inhibiting multiple steps of Fc epsilonRI signaling. Biol Pharm Bull 31: 442-448.
51. Kitamura Y, Go S, Hatanaka K, (1978). Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 52: 447-452.
52. Krauth MT, Majlesi Y, Sonneck K, Samorapoompichit P, Ghannadan M, Hauswirth AW, et al. (2006). Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cells. Allergy 61: 281-288.
53. Krauth MT, Mirkina I, Herrmann H, Baumgartner C, Kneidinger M, Valent P, (2009). Midostaurin (PKC412) inhibits immunoglobulin E-dependent activation and mediator release in human blood basophils and mast cells. Clin Exp Allergy 39: 1711-1720.
54. Kumada H, Mitsutake S, Inagaki Y, Mitsunaga S, Tsuchikawa H, Katsumura S, et al. (2007). Kinetics of the ceramide kinase inhibitor K1, a suppressor of mast-cell activation. Biosci Biotechnol Biochem 71: 2581-2584.
55. Lau HY, Kam MF, (2005). Inhibition of mast cell histamine release by specific phosphodiesterase inhibitors. Inflamm Res 54 (Suppl. 1): S05-S06.
56. Lee EJ, Ji GE, Sung MK, (2010). Quercetin and kaempferol suppress immunoglobulin E-mediated allergic inflammation in RBL-2H3 and Caco-2 cells. Inflamm Res 59: 847-854.
57. Lee JH, Kim JW, Ko NY, Mun SH, Her E, Kim BK, et al. (2008). Curcumin, a constituent of curry, suppresses IgE-mediated allergic response and mast cell activation at the level of Syk. J Allergy Clin Immunol 121: 1225-1231.
58. Li GZ, Chai OH, Song CH, (2005). Inhibitory effects of epigallocatechin gallate on compound 48/80-induced mast cell activation and passive cutaneous anaphylaxis. Exp Mol Med 37: 290-296.
59. Linwong W, Hirasawa N, Aoyama S, Hamada H, Saito T, Ohuchi K, (2005). Inhibition of the antigen-induced activation of rodent mast cells by putative Janus kinase 3 inhibitors WHI-P131 and WHI-P154 in a Janus kinase 3-independent manner. Br J Pharmacol 145: 818-828.
60. Lokeshwar BL, Selzer MG, Zhu BQ, Block NL, Golub LM, (2002). Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model. Int J Cancer 98: 297-309.
61. Malaviya R, Zhu D, Dibirdik I, Uckun FM, (1999). Targeting Janus kinase 3 in mast cells prevents immediate hypersensitivity reactions and anaphylaxis. J Biol Chem 274: 27028-27038.
62. Mastuda H, Morikawa T, Ueda K, Managi H, Yoshikawa M, (2002). Structural requirements of flavonoids for inhibition of antigen-Induced degranulation, TNF-alpha and IL-4 production from RBL-2H3 cells. Bioorg Med Chem 10: 3123-3128.
63. Masuda ES, Schmitz J, (2008). Syk inhibitors as treatment for allergic rhinitis. Pulm Pharmacol Ther 21: 461-467.
64. Matsuda H, Shimoda H, Yoshikawa M, (1999). Structure-requirements of isocoumarins, phthalides, and stilbenes from Hydrangeae Dulcis Folium for inhibitory activity on histamine release from rat peritoneal mast cells. Bioorg Med Chem 7: 1445-1450.
65. Matsuda H, Wang Q, Matsuhira K, Nakamura S, Yuan D, Yoshikawa M, (2008). Inhibitory effects of thunberginols A and B isolated from hydrangeae dulcis folium on mRNA expression of cytokines and on activation of activator protein-1 in RBL-2H3 cells. Phytomedicine 15: 177-184.
66. Mazuc E, Villoutreix BO, Malbec O, Roumier T, Fleury S, Leonetti JP, et al. (2008). A novel druglike spleen tyrosine kinase binder prevents anaphylactic shock when administered orally. J Allergy Clin Immunol 122: 188-194.
67. McEuen AR, Walls AF, (2008). Purification and characterization of mast cell tryptase and chymase from human tissues. Methods Mol Med 138: 299-317.
68. Mitsutake S, Kim TJ, Inagaki Y, Kato M, Yamashita T, Igarashi Y, (2004). Ceramide kinase is a mediator of calcium-dependent degranulation in mast cells. J Biol Chem 279: 17570-17577.
69. Miyata N, Gon Y, Nunomura S, Endo D, Yamashita K, Matsumoto K, et al. (2008). Inhibitory effects of parthenolide on antigen-induced microtubule formation and degranulation in mast cells. Int Immunopharmacol 8: 874-880.
70. Moon PD, Lee BH, Jeong HJ, An HJ, Park SJ, Kim HR, et al. (2007). Use of scopoletin to inhibit the production of inflammatory cytokines through inhibition of the IkappaB/NF-kappaB signal cascade in the human mast cell line HMC-1. Eur J Pharmacol 555: 218-225.
71. Moon TC, St Laurent CD, Morris KE, Marcet C, Yoshimura T, Sekar Y, et al. (2010). Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol 3: 111-128.
72. Moriya K, Rivera J, Odom S, Sakuma Y, Muramato K, Yoshiuchi T, et al. (1997). ER-27319, an acridone-related compound, inhibits release of antigen-induced allergic mediators from mast cells by selective inhibition of fcepsilon receptor I-mediated activation of Syk. Proc Natl Acad Sci U S A 94: 12539-12544.
73. Mroz P, Tegos GP, Gali H, Wharton T, Sarna T, Hamblin MR, (2007). Photodynamic therapy with fullerenes. Photochem Photobiol Sci 6: 1139-1149.
74. Murphy JJ, Heptinstall S, Mitchell JR, (1988). Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 2: 189-192.
75. Ninomiya M, Itoh T, Ishikawa S, Saiki M, Narumiya K, Yasuda M, et al. (2010). Phenolic constituents isolated from Fragaria ananassa Duch. inhibit antigen-stimulated degranulation through direct inhibition of spleen tyrosine kinase activation. Bioorg Med Chem 18: 5932-5937.
76. Norton SK, Dellinger A, Zhou Z, Lenk R, Macfarland D, Vonakis B, et al. (2010). A new class of human mast cell and peripheral blood basophil stabilizers that differentially control allergic mediator release. Clin Transl Sci 3: 158-169.
77. Nunomura S, Yoshimaru T, Ra C, (2008). Na-Tosyl-Phe chloromethyl ketone prevents granule movement and mast cell synergistic degranulation elicited by costimulation of antigen and adenosine. Life Sci 83: 242-249.
78. Oka T, Sato K, Hori M, Ozaki H, Karaki H, (2002). Xestospongin C, a novel blocker of IP3 receptor, attenuates the increase in cytosolic calcium level and degranulation that is induced by antigen in RBL-2H3 mast cells. Br J Pharmacol 135: 1959-1966.
79. Oka T, Kalesnikoff J, Starkl P, Tsai M, Galli SJ, (2012). Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice. Lab Invest 92: 1472-1482.
80. Okayama Y, Church MK, (1992). Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells. Int Arch Allergy Immunol 97: 216-225.
81. Okayama Y, Kawakami T, (2006). Development, migration, and survival of mast cells. Immunol Res 34: 97-115.
82. Okayama Y, Benyon RC, Rees PH, Lowman MA, Hillier K, Church MK, (1992). Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin Exp Allergy 22: 401-409.
83. Park HH, Lee S, Oh JM, Lee MS, Yoon KH, Park BH, et al. (2007). Anti-inflammatory activity of fisetin in human mast cells (HMC-1). Pharmacol Res 55: 31-37.
84. Park HH, Lee S, Son HY, Park SB, Kim MS, Choi EJ, et al. (2008). Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch Pharm Res 31: 1303-1311.
85. Patel RN, Attur MG, Dave MN, Patel IV, Stuchin SA, Abramson SB, et al. (1999). A novel mechanism of action of chemically modified tetracyclines: inhibition of COX-2-mediated prostaglandin E2 production. J Immunol 163: 3459-3467.
86. Pearce FL, Befus AD, Gauldie J, Bienenstock J, (1982). Mucosal mast cells. II. Effects of anti-allergic compounds on histamine secretion by isolated intestinal mast cells. J Immunol 128: 2481-2486.
87. Penissi AB, Vera ME, Mariani ML, Rudolph MI, Cenal JP, De Rosas JC, et al. (2009). Novel anti-ulcer alpha,beta-unsaturated lactones inhibit compound 48/80-induced mast cell degranulation. Eur J Pharmacol 612: 122-130.
88. Peterfy H, Toth G, Pecht I, Erdei A, (2008). C3a-derived peptide binds to the type I FcepsilonR and inhibits proximal-coupling signal processes and cytokine secretion by mast cells. Int Immunol 20: 1239-1245.
89. Rossi AB, Herlaar E, Braselmann S, Huynh S, Taylor V, Frances R, et al. (2006). Identification of the Syk kinase inhibitor R112 by a human mast cell screen. J Allergy Clin Immunol 118: 749-755.
90. Ruster GU, Hoffmann B, Hamburger M, (2004). Inhibitory activity of indolin-2-one derivatives on compound 48/80-induced histamine release from mast cells. Pharmazie 59: 236-237.
91. Sandler C, Ekokoski E, Lindstedt KA, Vainio PJ, Finel M, Sorsa T, et al. (2005). Chemically modified tetracycline (CMT)-3 inhibits histamine release and cytokine production in mast cells: possible involvement of protein kinase C. Inflamm Res 54: 304-312.
92. Shaik GM, Draberova L, Heneberg P, Draber P, (2009). Vacuolin-1-modulated exocytosis and cell resealing in mast cells. Cell Signal 21: 1337-1345.
93. Sheridan H, Frankish N, Farrell R, (1999). Synthesis and antispasmodic activity of analogues of natural pterosins. Eur J Med Chem 34: 953-966.
94. Sheridan H, Butterly S, Walsh JJ, Cogan C, Jordan M, Nolan O, et al. (2008). Synthesis and pharmacological activity of aminoindanone dimers and related compounds. Bioorg Med Chem 16: 248-254.
95. Sheridan H, Walsh JJ, Cogan C, Jordan M, McCabe T, Passante E, et al. (2009a). Diastereoisomers of 2-benzyl-2, 3-dihydro-2-(1H-inden-2-yl)-1H-inden-1- ol: potential anti-inflammatory agents. Bioorg Med Chem Lett 19: 5927-5930.
96. Sheridan H, Walsh JJ, Jordan M, Cogan C, Frankish N, (2009b). A series of 1, 2-coupled indane dimers with mast cell stabilisation and smooth muscle relaxation properties. Eur J Med Chem 44: 5018-5022.
97. Son JK, Son MJ, Lee E, Moon TC, Son KH, Kim CH, et al. (2005). Ginkgetin, a Biflavone from Ginko biloba leaves, inhibits cyclooxygenases-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. Biol Pharm Bull 28: 2181-2184.
98. Stenton GR, Lau HY, (1996). Inhibition of rat peritoneal mast cell exocytosis by frusemide: a study with different secretagogues. Inflamm Res 45: 508-512.
99. Suh PG, Park JI, Manzoli L, Cocco L, Peak JC, Katan M, et al. (2008). Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep 41: 415-434.
100. Suzuki H, Takei M, Yanagida M, Nakahata T, Kawakami T, Fukamachi H, (1997). Early and late events in Fc epsilon RI signal transduction in human cultured mast cells. J Immunol 159: 5881-5888.
101. Vendelin J, Laitinen C, Vainio PJ, Nissinen E, Maki T, Eklund KK, (2005). Novel sulfhydryl-reactive compounds orazipone and OR-1958 inhibit cytokine production and histamine release in rat and human mast cells. Int Immunopharmacol 5: 177-184.
102. Wang Q, Matsuda H, Matsuhira K, Nakamura S, Yuan D, Yoshikawa M, (2007). Inhibitory effects of thunberginols A, B, and F on degranulations and releases of TNF-alpha and IL-4 in RBL-2H3 cells. Biol Pharm Bull 30: 388-392.
103. Weston MC, Anderson N, Peachell PT, (1997). Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function. Br J Pharmacol 121: 287-295.
104. Yuan M, Li J, Lv J, Mo X, Yang C, Chen X, et al. (2012). Polydatin (PD) inhibits IgE-mediated passive cutaneous anaphylaxis in mice by stabilizing mast cells through modulating Ca(2+) mobilization. Toxicol Appl Pharmacol 264: 462-469.